Daiichi Sankyo Company, Limited (DSKYF) Q3 2024 Earnings Call Transcript Summary

moomoo AIJan 31 22:23 ET · Conference Call

Daiichi Sankyo Sees ENHERTU Sales Reaching ¥539.9B in FY2024 Amid Oncology Momentum

Seeking AlphaJan 31 22:21 ET

Daiichi Sankyo Reports 9M Results

Seeking AlphaJan 31 10:56 ET

AstraZeneca, Daiichi Win EU Backing for Breast Cancer Drug Dato-DXd

Seeking AlphaJan 31 09:08 ET

J.P. Morgan Maintains DAIICHI SANKYO COMPANY LIMITED(DSKYF.US) With Buy Rating, Cuts Target Price to $38.8

Moomoo NewsJan 29 07:34 ET · Ratings

FDA Approves AstraZeneca, Daiichi Sankyo's Enhertu For Certain Type Of Breast Cancer Patients

BenzingaJan 28 10:29 ET